Gram-negative bacteria as causative agents of ventilator-associated pneumonia and their respective resistance

Daniela Bandić-Pavlović1,2, Tajana Zah-Bogović1,2, Marta Žižek3

  • 1Department of Anesthesiology, School of Medicine, University of Zagreb, Zagreb, Croatia.

Insights

Multidrug-resistant Gram-negative bacteria, including Acinetobacter baumannii and Pseudomonas aeruginosa, are a significant threat in intensive care units (ICUs). This study identified high rates of resistance and diverse resistance mechanisms, highlighting the urgent need for effective antimicrobial strategies.

Area of Science:

  • Clinical Microbiology
  • Infectious Diseases
  • Intensive Care Medicine

Background:

  • Ventilator-associated pneumonia (VAP) is a critical complication in intensive care units (ICUs), contributing significantly to patient mortality.
  • Multidrug-resistant Gram-negative bacteria, particularly Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae, are frequently implicated in ICU-acquired VAP.
  • Understanding the prevalence and resistance mechanisms of these pathogens is crucial for developing effective treatment and prevention strategies.

Purpose of the Study:

  • To investigate the antibiotic susceptibility patterns of Gram-negative bacteria isolated from VAP patients in Croatian ICUs.
  • To identify the prevalence of specific resistance genes, including those for extended-spectrum beta-lactamases (ESBLs) and carbapenemases.
  • To elucidate the genetic mechanisms underlying multidrug resistance in key Gram-negative pathogens causing VAP.

Main Methods:

  • Prospective study conducted in four ICUs between September 2017 and March 2018.
  • Antibiotic susceptibility testing performed using broth microdilution.
  • Detection of ESBLs, carbapenemases (Hodge test, carbapenem inactivation method), and resistance genes (PCR for bla genes, qnr genes).

Main Results:

  • High resistance rates observed in Pseudomonas aeruginosa against imipenem (74%) and meropenem (68%).
  • Acinetobacter baumannii isolates exhibited extensive resistance, with most strains resistant to carbapenems and other antibiotics, except colistin and amikacin.
  • Prevalence of specific resistance genes: blaOXA-23/24 in A. baumannii, CTX-M group 1 in K. pneumoniae and E. cloacae, CMY family in P. mirabilis, and OXA-48/VIM-1 in K. pneumoniae and E. cloacae.

Conclusions:

  • A high proportion of multidrug-resistant Pseudomonas aeruginosa, Klebsiella pneumoniae, and extensively resistant Acinetobacter baumannii were identified.
  • Acquired resistance mechanisms, primarily carbapenemase and ESBL production, were dominant in A. baumannii and K. pneumoniae.
  • Resistance in P. aeruginosa likely involves efflux pump upregulation or porin loss, with significant diversity of beta-lactamases found in Enterobacteriaceae.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
596
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
911
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.2K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
2.4K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.2K
Mechanical Ventilation II: Invasive Ventilation01:23

Mechanical Ventilation II: Invasive Ventilation

Ventilators are essential medical equipment used to aid patients with respiratory difficulties. Their primary function is to assist or replace spontaneous breathing by providing mechanical ventilation. There are two general classes of mechanical ventilators: negative-pressure and positive-pressure ventilators.
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
492